The effect of the 5‐HT7 serotonin receptor agonist, LP44, on micturition in rats with chronic spinal cord injury
Authors:
- 16 July 2013
- journal article
- basic science
- Published by Wiley in Neurourology and Urodynamics
- Vol. 33 (7) , 1165-1170
Abstract
Aims: To better understand the effects of the selective 5‐HT7 receptor agonist 4‐[2‐(Methylthio)phenyl]‐N‐(1,2,3,4‐tetrahydro‐1‐naphthalenyl)‐1‐piperazinehexanamide hydrochloride (LP44) on micturition in spinal cord injury (SCI) rats.Methods: Female Sprague‐Dawley rats weighing 200–275 g were used. SCI was produced in 8 of the 16 rats by transection at the T10 level; cystometric study occurred 8–12 weeks post‐transection. Intravesical pressure was monitored in urethane‐anesthetized animals via a transvesical catheter. The selective 5‐HT7 antagonist (R)‐3‐[2‐[2‐(4‐Methylpiperidin‐1‐yl)ethyl]pyrrolidine‐1‐sulfonyl] phenol hydrochloride (SB‐269970) was administered after each LP44 dose–response curve (all drugs were administered intravenously, i.v).Results: Compared to controls, SCI rats had a higher bladder capacity and residual volume, and a lower voiding efficiency. In SCI rats, LP44 (0.003–0.3 mg/kg, i.v) induced significant dose‐dependent increases in micturition volume, significant dose‐dependent decreases in residual volume, resulting in significant increases in voiding efficiency. CMG measurements showed a dose‐dependent increase of the high‐frequency oscillation (HFO) activity, including the number of small oscillation per voiding. This was correlated with the improved voiding efficiency. SB‐269970 (0.1 mg/kg, i.v) partially or completely reversed all LP44‐induced changes.Conclusions: HFOs seems to be correlated with external urethral sphincter (EUS) bursting activity during voiding. Both the bladder voiding efficiency and the periodic EUS activity were decreased in SCI rats. 5‐HT7 receptor agonist can enhance HFO activity, thereby improving voiding efficiency. Whether or not these results may have implications for the future treatment of voiding dysfunction in SCI patients remains to be studied. Neurourol. Urodynam. 33:1165–1170, 2014.Keywords
Funding Information
- National Natural Science Foundation of China (30872568)
- Science and Technology Commission of Shanghai Municipality (09QH1402000)
This publication has 23 references indexed in Scilit:
- Diabetic Urethropathy Compounds the Effects of Diabetic CystopathyJournal of Urology, 2007
- Activation of the external urethral sphincter central pattern generator by a 5-HT1A receptor agonist in rats with chronic spinal cord injuryAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: Immunocytochemical evidenceJournal of Comparative Neurology, 2005
- Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT7 receptorEuropean Journal of Pharmacology, 2000
- Autoradiographic study of ?1- and ?2-noradrenergic and serotonin1A receptors in the spinal cord of normal and chronically transected catsJournal of Comparative Neurology, 1999
- Vesicourethral function in diabetic patients: Association of abnormal nerve conduction velocity with vesicourethral dysfunctionNeurourology and Urodynamics, 1999
- Diabetic Cystopathy: Relationship to Autonomic Neuropathy Detected by Sympathetic Skin ResponseJournal of Urology, 1997
- Effects of dorsal rhizotomy and selective lesion of serotonergic and noradrenergic systems on 5-HT1a , 5-HT1b and 5-HT3 receptors in the rat spinal cordJournal of Neural Transmission, 1995
- Spinal supersensitivity to 5-HT1, 5-HT2 and 5-HT3 receptor agonists following 5,7-dihydroxytryptamineEuropean Journal of Pharmacology, 1994
- Origins of serotonergic projections to the spinal cord in rat: An immunocytochemical-retrograde transport studyBrain Research, 1981